content

NRx Pharma Announces Partnership with the IIBR to Complete Development and Commercialization of BriLife COVID Vaccine

NRx Pharmaceuticals, a clinical stage pharmaceutical company announced that it has signed a Memorandum Of Understanding with the Government of Israel to license exclusive...

Genoskin launches the ISR platform: the first human skin ex vivo platform to study injection site reactions ahead of clinical trials

Genoskin announces the launch of the ISR platformยฎ, a new pre-clinical toolbox designed to study injection site reactions (ISR) in humans ahead of clinical...

Moderna COVID-19 vaccine approved for use in Saudi Arabia

Saudi Arabia has approved the Moderna coronavirus vaccine for emergency use, making it the fourth jab to be administered in the Kingdom along with...

Bridging the Gaps in Complex Patient Journeys by Enriching Data

Generating insights about patients on specialty therapies through data aggregation and integration can improve patient outcomes As the number of specialty drugs expands in complex...

LGM Pharma launches standalone analytical services for drug developers and manufacturers

LGM Pharma announced the launch of its new Analytical Services offering that provides analytical testing and stability services to pharmaceutical developers and manufacturers, including...

Novasep signs a manufacturing services agreement with Exelixis for a next-generation ADC

Novasep, a leading supplier of services and technologies for the life sciences industry, is pleased to announce the signature of a manufacturing services agreement...

Valneva Awarded FDA Breakthrough Designation for its Single-Shot Chikungunya Vaccine Candidate

Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, announced...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read